Recent KALV Stock Price | KALV Stock Predictions | |
$9.62 | ![]() +171.52% |
$26.12 |
Recent KALV Analyst Ratings Breakdown, Making KALV Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 8 | 6 | 5 | 5 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.11 | 1.14 | 1.17 | 1.17 |
For the KALV stock predictions from the analysts covering KalVista Pharmaceuticals Inc, we have collected all of the individual KALV stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 8 different analysts covering KALV (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since KALV stock predictions may vary widely, another useful metric to consider is the median KALV stock prediction, which represents the price at which half of the analysts
made KALV stock predictions that were higher and half made KALV stock predictions that were lower. This makes for a different take on the KALV stock predictions out there, as compared to average or mean.
And that median across all the individual KALV stock predictions was: $25.0 as of 2025-02-07.
The very highest of the KALV stock predictions for one year price target was $39.0, while the very lowest of the KALV stock predictions in the analyst group was
$18.0 (with a standard deviation of $7.586). Get the latest Zacks research report on KALV — FREE
Find out: KALV next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
WELL Stock Predictions
ITUB Stock Predictions
SCHL Stock Predictions
QFIN Stock Predictions
FCF Stock Predictions
CTMX Stock Predictions
LEU Stock Predictions
IPGP Stock Predictions
IART Stock Predictions
![]()
![]() |
![]() ![]() |
![]() ![]() |
![]() ![]() |
![]() Strong Buy (3.89 out of 4) 77th percentile
(ranked higher than approx. 77% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com ![]() |
![]() ![]() |